Importantly, HMAs also increased expression levels of PD-1, PD-L1 and CTLA-4 on peripheral blood (PB) mononuclear cells from MDS and AML patients as well as on leukemia cell lines (Figure 1) [50]. The gene discussed is CD274; the disease is acute myeloid leukemia.